Sorafenib after Arterial Chemoembolization in Child-Pugh A and B Cirrhotic Patients with Intermediate Hepatocellular Carcinoma: A Retrospective Analysis

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations

"Sorafenib after Arterial Chemoembolization in Child-Pugh A and B Cirrhotic Patients with Intermediate Hepatocellular Carcinoma: A Retrospective Analysis"
written by Fernando Gomes Romeiro, Luciana Yumi Odani Sigahi, Matheus Alvarez, Fabio da Silva Yamashiro, Fábio Cardoso de Carvalho, Leonardo Pelafsky, Talles Bazeia Lima, Letícia de Campos Franzoni, José Ricardo de Arruda Miranda, Giovanni Faria Silva,
published by Journal of Cancer Therapy, Vol.6 No.3, 2015

has been cited by the following article(s):

[1]	Resposta objetiva tumoral e taxas de sobrevida de pacientes com cirrose e carcinoma hepatocelular submetidos à radioembolização com ¹³¹I-lipiodol versus …
	2023

[2]	How Much Time Should Be Waited and What Are the Main Findings to Evaluate the Hepatocellular Carcinoma Response to Regorafenib? A Real-Life …
	2021

[3]	Research Article How Much Time Should Be Waited and What Are the Main Findings to Evaluate the Hepatocellular Carcinoma Response to Regorafenib? A …
	2021

[4]	How Much Time Should Be Waited and What Are the Main Findings to Evaluate the Hepatocellular Carcinoma Response to Regorafenib? A Real‐Life Experience
	Canadian Journal of …, 2021

[5]	Combined strategies for hepatocellular carcinoma treatment: a new hope
	2017

[6]	Combining loco-regional treatments in early hepatocellular carcinoma: new achievements overcoming old limitations
	2017

Follow SCIRP